Our Specialists

George Miltiadous MD, PhD, FASA, FEFIM

Internal Medicine

Mail Address: Agathokleous Str, 2000 Strovolos, Nicosia, Cyprus
Telephone: +357 22502295
Email: g.miltiadous@hippocrateon.com

 

For the full CV of the Doctor in Greek language please click here.

 

Surname: Miltiadous
Name: George
Father Name: Andreas
Year of Birth: 1971
Place of Birth: Nicosia, Cyprus
Postal Address: Agathokleous Str, 2000 Strovolos, Nicosia, Cyprus.
Lyceum Certificate: 1989 (Acropolis Lyceum, Nicosia, with Honors)
Admission to Medical School University of Ioannina: 1991
Graduation from Medical School: 1997 [with Honors]
Marital Status: Married to Agni Procopiou, Bank Clerk, Father of a 3 years boy
Foreign Language: English (First Certificate in English, Grade: Β, GCE O Level Grade: C)
PhD Thesis: <Genetic and environmental factors affecting the response to statin therapy>, Department of Internal Medicine, Medical School, University of Ioannina, September 2003 [with Honors]
Regency Program in Internal Medicine: From 2000-2005 in the Second Internal Medicine Department of the University Hospital of Ioannina
Qualified as an Internal Medicine Physician: 25/10/2005 (upon competition of the national exam)
Regency Program in Angiology and Vascular Sonography: From 2005-2006 in the Radiology Department of the University Hospital of Ioannina
Fellow of the American Society of Angiology (FASA) : From 21/10/2004
Fellow of the Hellenic Society of Atherosclerosis: From 2002
Fellow of the Hellenic Society of the Study of Hypertension: From 2004
Fellow of the European Federation of Internal Medicine: From 2006
Individual Member of International Atherosclerosis Society: From 2006
Distinctions: participation in the 5η edition of Who’s Who in Medicine and Healthcare, participation in The Cambridge Blue Book-2005
Fields of Interest: 1) Lipid metabolism
2) Hypertension
3) Electrolyte and acid-base abnormalities


Abstracts at International Congresses

INTERNATIONAL FORUM ON ANGIOTENSIN II RECEPTOR ANTAGONISM
Monte–Carlo, 27-30 January 1999

1.Elisaf M, Tsimihodimos V, Bairaktari E, Katsaraki A, Tzallas Ch,    Liberopoulos E, Miltiadous G, Achimastos A. The addition of losartan to fenofibrate treatment has an additive hypouricemic effect in hypertensive dyslipidemic patients with hyperuricemia.

SECONDARY DYSLIPIDEMIAS. PRE-CONGRESS SATELLITE SYMPOSIUM, 71ST EAS CONGRESS
Delphi-Greece, 24-26 May 1999

2. Elisaf M, Tsimihodimos V, Bairaktari E, Katsaraki A, Tzallas Ch, Miltiadous G, Liberopoulos E, Milionis H, Achimastos A, Siamopoulos KC. Effect of micronised fenofibrate and losartan combination on uric acid metabolism in hypertensive dyslipidemic patients with hyperuricemia.

3. Tsimihodimos V, Milionis H, Bairaktari E, Tzallas Ch, Miltiadous G, Katsaraki A, Liberopoulos E, Elisaf M. The incidence of thyroid function abnormalities in patients attending an outpatient lipid clinic.

71ST EUROPEAN ATHEROSCLEROSIS SOCIETY CONGRESS
Athens-Greece, 26-29 May 1999

4. Miltiadous G, Bairaktari E, Tzallas C, Tsimihodimos V, Liberopoulos E, Milionis H, Rizos E, Elisaf M. Comparison of the efficacy of atorvastatin and micronised fenofibrate in the treatment of mixed hyperlipidemia.

5. Liberopoulos E, Tsimihodimos V, Bairaktari E, Tzallas Ch, Rizos E, Katsaraki A, Miltiadous G, Elisaf M. Effect of fluvastatin on plasma fibrinogen levels.

5TH INTERNATIONAL SYMPOSIUM MULTIPLE RISK FACTORS IN CARDIOVASCULAR DISEASE: GLOBAL ASSESSMENT AND INTERVENTION
Venice-Italy, 28 - 31 October 1999

6. Tsimichodimos V, Milionis H, Bairaktari E, Tzallas Ch, Miltiadous G, Katsaraki A, Liberopoulos E, Rizos E, Elisaf M. Thyroid function abnormalities in patients visiting an outpatient lipid clinic.

72ND CONGRESS OF THE EUROPEAN ATHEROSCLEROSIS SOCIETY
Glasgow-UK, 20-23 May 2001

7. Miltiadous G, Xenophontos S, Bairaktari E, Tsimihodimos V, Tselepis A, Karabina S-A, Liberopoulos E, Cariolou M, Elisaf M. Characterisation of the low density lipoprotein receptor gene mutations causing familiar hypercholesterolaemia in northwestern Greece.

8. Miltiadous G, Xenophontos E, Bairaktari E, Tsimihodimos V, Milionis H, Tselepis A, Liberopoulos E, Cariolou M, Elisaf M. Lp(a) concentrations and effectiveness of statin therapy in patients with homozygous familiar hypercholesterolemia carrying a class V mutation.

9. Miltiadous G, Hatzivassiliou M, Pasiardi I, Bairaktari E, Tsimihodimos V, Elisaf M, Cariolou M. Apolipoprotein A-IV polymorphisms: frequency and effects on lipids and apolipoproteins among individuals in Northwestern Greece.

10. Miltiadous G, Xenophontos E, Bairaktari E, Tsimihodimos V, Milionis H, Tselepis A, Liberopoulos E, Cariolou M, Elisaf M. Lp(a) concentrations and effectiveness of statin therapy in patients with homozygous familiar hypercholesterolemia carrying a class V mutation.

XIV INTERNATIONAL SYMPOSIUM ON DRUGS AFFECTING LIPID METABOLISM
New York-USA, 9-11 September 2001

11. Tsimihidimos V, Kakafika A, Liberopoulos E, Miltiadous G, Liamis G, Bairaktari E, Elisaf M. Effect of atorvastatin on serum uric acid levels.

EUROMEDLAB 2001, 14th IFCC-FESCC EUROPEAN CONGRESS OF CLINICAL CHEMISTRY AND LABORATORY MEDICINE
Prague-Czech, 26-31 May 2001

12. Bairaktari E, Papavasiliou E, Tzallas C, Kakafica A, Miltiadous G, Liberopoulos E, Cariolou M, Elisaf M, Tsolas O. Association of apolipoprotein E concentrations with apo E phenotype and lipid levels in normal subjects and hyperlipidemic patients.

9TH MEETING OF THE BALKAN CLINICAL LABORATORY FEDERATION
Ioannina-Greece, 12-15 September 2001

13. Bairaktari E, Papavasiliou E, Tzallas C, Kakafica A, Miltiadous G, Liberopoulos E, Cariolou M, Kalaitzidis R, Siamopoulos K, Elisaf M, Tsolas O. Apolipoprotein Ε concentrations in various pathological situations.

4TH EUROPEAN CONGRESS OF CHEMOTHERAPY AND INFECTION
Paris-France, 4-7 May 2002

14. Tsiara S, Miltiadous G, Milionis C, Elisaf M. Invasive Group B streptococcal infection in a healthy adult.

73RD CONGRESS OF THE EUROPEAN ATHEROSCLEROSIS SOCIETY
Salzburg-Austria, 7-10 July 2002

15. Milionis H, Liberopoulos E, Miltiadous G, Tzallas C, Bairaktari E, Elisaf M. Lipid parameters in elderly patients suffering first acute ischemic stroke.

5TH EUROPEAN CONGRESS OF CHEMOTHERAPY AND INFECTION
Rhodes-Greece, 17-20 October 2003

16. Pappas G, Miltiadous G, Raptis C, Elisaf M, Tsianos E. Morganella morganii bacteraemia in nursing home residents.

INTERNATIONAL MEETING OF THE MOVEMENT DISORDER SOCIETY
Innsbruck-Austria, 19-21 February 2003

17. Konitsiotis S, Markoula S, Mokou C, Argyropoulou M, Miltiadous G, Kyritsis T. Cryptic angiomatosis of the central nervous system presenting as progressive supranuclear palsy.

74TH CONGRESS OF THE EUROPEAN ATHEROSCLEROSIS SOCIETY
Seville-Spain, 17-20 April 2004

18. Liberopoulos E, Miltiadous G, Hatzivasiliou M, Pasiardi I, Tsimihodimos V, Bairaktari E, Cariolou M, Elisaf M. Apolipoprotein E polymorphism in Northwestern Greece: Frequency and effect on lipid parameters.

19. Miltiadous G, Hatzivasiliou M, Xenophontos E, Bairaktari E, Cariolou M, Elisaf M. Taq IB polymorphism of the cholesteryl ester transfer protein in a Greek population and its relation to serum lipid and lipoprotein levels.

20. Miltiadous G, Xenophontos S, Tsimihodimos V, Cariolou M, Elisaf M. Characterization of the low density lipoprotein receptor gene mutations causing familial hypercholesterolaemia in Northwestern Greece.

21. Miltiadous G, Xenophontos S, Bairaktari E, Tsimihodimos V, Kalogirou M, Cariolou M, Elisaf M. Genetic and environmental factors affecting the response to statin therapy in patients with familial hypercholesterolaemia.

XV INTERNATIONAL SYMPOSIUM ON DRUGS AFFECTING LIPID METABOLISM
Venice-Italy, 24-27 October 2004

22. Miltiadous G, Liberopoulos E, Hatzivassiliou M, Ayrton N, Bairaktari E, Cariolou M, Elisaf M. Apolipoprotein E polymorphism in northwestern Greece: Frequency and effect on lipid parameters.

23. Miltiadous G, Xenophontos S, Dimitriou N, Bairaktari E, Cariolou M, Elisaf M. Genetic and environmental factors affecting the response to statin therapy in patients with molecularly defined familial hypercholesterolemia.

75TH CONGRESS OF THE EUROPEAN ATHEROSCLEROSIS SOCIETY
Prague-Czech, 23-26 April 2005

24. Cariolou M, Hadjivassiliou M, Demetriou N, Marcou A, Karagrigoriou A, Miltiadous G, Elisaf M. HDL-cholesterol, smoking and IL13R130Q polymorphism are associated with myocardial infraction in Greek Cypriot males.

25. Kostara C, Papathanasiou A, Cung M, Miltiadous G, Seferiadis K, Elisaf M, Goudevenos I, Bairaktari E. Total plasma lipid analysis in patients with established coronary heart disease by H-NMR spectroscopy.

26. Liberopoulos E, Miltiadous G, Cariolou M, Katopodis K, Tselepis A, Siamopoulos K, Elisaf M. The influence of serum apolipoprotein E concentration and polymorphism on serum lipid parameters in hemodialysis patients.

27. Liberopoulos E, Miltiadous G, Cariolou M, Christidis D, Siamopoulos K, Elisaf M. Does apolipoprotein E polymorphism affect renal function and serum uric acid levels in healthy subjects?

13TH MEETING OF BALKAN CLINICAL LABORATORY FEDERATION
Tirana-Albania, 28 September-1 October 2005

28. Bulo A, Refatllari E, Heta E, Goda A, Refatllari A, Doko A, Simoni L, Temali I, Xenophontos S, Cariolou M, Miltiadous G, Elisaf M. Characterization of the low density lipoprotein receptor gene mutations causing familial hypercholesterolaemia in Albania.

AWARDS

1. Miltiadous G, Xenophontos S, Bairaktari Ε, Tsimihodimos V, Liamis G, Liberopoulos E, Cariolou Μ, Goudevenos J, Papathanasiou T, Elisaf M. The use of genetic markers in the diagnosis of familial hypercholesterolemia. Accolade 22nd Panellinio Cardiology Congress, 22-24 November 2001, Thessalonica.

2. Miltiadous G, Bairaktari Ε, Xenophontos S, Manoli P, Cariolou Μ, Goudevenos J, Elisaf M. LDL receptor gene mutations causing familial hypercholesterolemia in northwestern Greece. First Award 3rd North Greece Cardiology Congress, 16-18 May 2002, Thessalonica.

3. Miltiadous G, Bairaktari Ε, Xenophontos S, Manoli P, Goudevenos J, Elisaf M. Geographic distribution of the LDL receptor gene mutations in northwestern Greece. First Award Odysseus Kaligiannis 11ου Pankritiou Medical Congress, 1-3 November 2002, Xania.

4. Miltiadous G, Xatzivasiliou M, Pasiardi I, Bairaktari Ε, Cariolou Μ, Elisaf M. Frequency and effect of apolipoprotein A IV on lipid parameters in Greek individuals. First Award 29th Panellinio Medical Congress, 20-24 May 2003, Athens.

5. Liamis G, Liberopoulos E, Miltiadous G, Christidis D, Bairaktari Ε, Kalogirou M, Tzovaras V, Tsianos E, Siamopoulos C, Elisaf M. Therapeutic approach of patients with sodium disorders. Award Η. Fili, 9th Panellinio Congress of Internal Medicine, 6-11 Octomber 2003, Athens.

6. Liberopoulos Ε, Miltiadous G, Cariolou M, Bairaktari E, Athiros V, Siamopoulos C, Elisaf M. The effect of apolipoprotein E on plasma creatine and urate levels in control population. 3th Award 10th Panellinio Congress of Internal Medicine, 4-9 Octomber 2004, Athens.

7. Miltiadous G, Xenophontos S, Kalogirou M, Tzovaras V, Bairaktari E, Zotou A, Cariolou Μ, Elisaf M. LDL receptor gene mutations causing familial hypercholesterolemia in northwestern Greece. Accolade 1st  Panellinio Congress of Hellenic Society of Atherosclerosis.